This trial is currently accepting new patient applications.(Apply)
Objective
Study evaluating the effectiveness of a new medication for the treatment of stress urinary incontinence.
Patient
Eligibility
For
More Information
For additional information on inclusion and exclusion criteria and whether or not you may be a candidate to participate in a trial, call Nazy Zomorodian, Director for the Clinical Trials Office at (310) 825-5538.